ionis tmprss6-lrx
Nucleic acidexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jun 6, 2017 (NCT03165864)
Timeline
Indications
Mechanism of action
- Transmembrane protease serine 6ANTISENSE INHIBITOR
TMPRSS6 antisense inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ionis tmprss6-lrx
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04059406 | Phase 2 | Nov 30, 2019 | Ionis Pharmaceuticals, Inc. |
| NCT03165864 | Phase 1 | Jun 6, 2017 | Ionis Pharmaceuticals, Inc. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Ionis Pharmaceuticals, Inc. | For profit | 2 | 2 | 2 | 2017 |
1 organizations
Page 1 / 1